Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the Lazard Capital Markets 9th Annual Healthcare
Conference being held in New York City. Harvey J. Berger, M.D., chairman
and chief executive officer, will provide an overview of the Company's
progress on Wednesday, November 14, 2012 at 1:30 p.m. (ET).
The ARIAD presentation at the Lazard Capital Markets 9th
Annual Healthcare Conference will be webcast live and can be accessed by
visiting the investor reations section of the Company's website at http://www.ariad.com/investor.
A replay of the presentation will also be available and archived on the
site for three weeks.
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company
focused on the discovery, development and commercialization of medicines
to transform the lives of cancer patients. ARIAD's approach to
structure-based drug design has led to several internally discovered,
molecularly targeted product candidates for drug-resistant or
difficult-to-treat cancers, including certain forms of chronic myeloid
leukemia and non-small cell lung cancer. For additional information,
or follow ARIAD on Twitter
[ Back To NFVZone's Homepage ]